# ABLATE WEIGHT 2 (Single-Stage Fundic Ablation Plus ESG for Weight Loss)

> **NCT05992103** · NA · UNKNOWN · sponsor: **True You Weight Loss** · enrollment: 10 (estimated)

## Conditions studied

- Obesity

## Interventions

- **PROCEDURE:** Fundic Ablation in Combination with Endoscopic Sleeve Gastroplasty
- **DEVICE:** Fundic Mucosal Ablation with ERBE HybridAPC
- **DEVICE:** Apollo ESG

## Key facts

- **NCT ID:** NCT05992103
- **Lead sponsor:** True You Weight Loss
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-14
- **Primary completion:** 2025-04-14
- **Final completion:** 2025-05-15
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2023-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05992103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05992103, "ABLATE WEIGHT 2 (Single-Stage Fundic Ablation Plus ESG for Weight Loss)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT05992103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*